Also trades as: IPN.PA (PAR) · $vol 18M · IPSEY (OTC) · $vol 0M

$113.13

+0.00 (+0.00%)

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 50 · $9.4B mcap · 34M float · 0.0001% daily turnover · Short 100% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Income Trends

Revenue

$3.7B +2.8% ▲

5Y CAGR: +6.5%

Gross Profit

$2.6B -12.3% ▼

5Y CAGR: +3.4%

Operating Income

$746M +50.2% ▲

5Y CAGR: +7.4%

Net Income

$444M +28.5% ▲

5Y CAGR: -4.1%

EPS (Diluted)

$5.32 +28.5% ▲

5Y CAGR: -4.1%

EBITDA

$1.1B -5.1% ▼

5Y CAGR: +6.8%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$3.0B	$3.2B	$3.3B	$3.6B	$3.7B
YoY Growth	+11.7%	+5.2%	+4.7%	+8.1%	+2.8%
Cost of Revenue	$538M	$528M	$571M	$619M	$1.1B
Gross Profit	$2.5B	$2.6B	$2.7B	$3.0B	$2.6B
Gross Margin	82.1%	83.3%	82.7%	82.7%	70.6%
R&D Expenses	$428M	$445M	$619M	$687M	$0
SG&A Expenses	$1.0B	$1.0B	$1.1B	$1.2B	$0
Operating Expenses	$1.6B	$1.8B	$1.9B	$2.5B	$1.8B
Operating Income	$850M	$730M	$816M	$497M	$746M
Operating Margin	28.3%	23.1%	24.7%	13.9%	20.3%
Interest Expense	$24M	$18M	$38M	$24M	$36M
Income Before Tax	$814M	$706M	$756M	$432M	$578M
Tax Expense	$168M	$112M	$136M	$75M	$134M
Net Income	$647M	$649M	$644M	$346M	$444M
Net Margin	21.6%	20.5%	19.5%	9.7%	12.1%
EPS (Diluted)	$7.76	$7.81	$7.40	$4.14	$5.32
EBITDA	$1.1B	$938M	$887M	$1.2B	$1.1B
Shares Outstanding	83M	83M	83M	83M	84M

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$1.6B	$1.5B	$1.6B	$876M	$2.7B	$2.1B	$1.5B	$2.2B
Cost of Revenue	$286M	$270M	$301M	$158M	$460M	$383M	$698M	$435M
Gross Profit	$1.3B	$1.3B	$1.3B	$718M	$2.2B	$1.8B	$833M	$1.8B
Gross Margin	82.1%	82.4%	81.1%	81.9%	82.9%	82.1%	54.4%	80.1%
R&D Expenses	$238M	$290M	$329M	$162M	$525M	$365M	$389M	$402M
SG&A Expenses	$552M	$553M	$582M	$287M	$886M	$607M	$557M	$607M
Operating Expenses	$723M	$756M	$819M	$559M	$1.9B	$1.0B	$841M	$900M
Operating Income	$583M	$510M	$471M	$159M	$338M	$755M	$488M	$853M
Operating Margin	36.6%	33.2%	29.6%	18.1%	12.5%	35.2%	31.9%	39.0%
Interest Expense	$12M	$15M	$11M	$11M	$13M	$18M	$18M	$3M
Income Before Tax	$215M	$261M	$529M	$145M	$287M	$501M	$153M	$547M
Tax Expense	$4M	$56M	$80M	$24M	$51M	$105M	$28M	$145M
Net Income	$254M	$195M	$449M	$116M	$230M	$393M	$51M	$402M
Net Margin	16.0%	12.7%	28.2%	13.2%	8.5%	18.4%	3.3%	18.4%
EPS (Diluted)	$3.07	$2.35	$5.38	$1.45	$2.69	$4.71	$0.61	$4.85
EBITDA	$260M	$318M	$672M	$241M	$920M	$750M	$352M	$853M
Shares Outstanding	83M	83M	84M	83M	83M	84M	82M	83M

IPSEF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet